U.S., Nov. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07930923) titled 'Bictegravir Efficacy With 1st INSTI Generation Failure History' on July 28.
Brief Summary: Retrospective observational study using Data that was Previously Collected This is a retrospective cohort study based on the secondary analysis of data from the Nadis database. The study population will consist of all Virologically Suppressed (VS), or Virologically Unsuppressed (VU) Experienced patients at the time of switching to B/F/TAF, who had previously experienced treatment failure with first-generation InSTI before switching to B/F/TAF, who started B/F/TAF between January 1, 2019 and December 31, 2022, who had previously signed a consen...